Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment

The aim of the study is to compare the exposure to environmental and professional toxics by patients with systemic scleroderma and by patients not achieved by this pathology.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Systemic Scleroderma Connective Tissue Diseases Scleroderma, Systemic Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Rennes

Rennes, France

About this study

This study is based on a questionnaire.

The data will be collected according a retrospective and prospective design :

at diagnostic of the disease
at the inclusion in the systemic scleroderma cohort
during the annual visit (in 2017-2018-2019-2020)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with systemic scleroderma

Exclusion criteria

Treatment and study plan

Primary outcomes

Questionnaire to evaluate the exposition of environmental and professional toxics

Time frame: once a year up to 2020

clinical, personal and professional data

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Acronym: PRESSY

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2022
First posted: Aug 25, 2017
Registry last updated: Apr 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed